Beruflich Dokumente
Kultur Dokumente
SECTION:
• Reagent Strip Tray
• SPR Block
• Operating Status Light
• Microprocessor
• Incubators
• Strip Preparation Tray
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
SECTION:
• Reagent Strip Tray
• SPR Block
• Operating Status Light
• Microprocessor
• Incubators
• Strip Preparation Tray
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
SECTION:
• Reagent Strip Tray
• SPR Block
• Operating Status Light
• Microprocessor
• Incubators
• Strip Preparation Tray
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
Strip
Preparation
Tray
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
Detection
System:
Fluorometric
Scanner
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
Display Screen
Option
Selection Keys
Function Keys
Arrow Keys
Numeric
Keypad
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
Internal Printer
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
Reference:
1. Memory Card Slot
2. Diagnostic Port
3. Computer Port
4. Printer Port
5. AC Power Connection
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
Diagnostic Port
Computer Port
Printer Port
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
Selection
Selection Status
Labels
Selection
Selection Status
Labels
Screen Label
Standard,
Position #
Control
Start/Halt
Assay Code
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
Print
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
Errorcode: 73
Time: 14:53:20
14/09/15
MLE Card data bad
The mixture is
cycled in and out
of the SPR
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
The sensitized
Anti-TSH Antibody
will formed a
sandwich complex
with the antibody
present inside the
SPR
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
Catalyzes the
hydrolysis of this
substrate into a
fluorescent (4-methyl-
umbelliferone) and
measured at 450nm
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
T3/TRIIODOTHYRONINE
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
T3/TRIIODOTHYRONINE
• the quantitative measurement of total
triiodothyronine (T3) in human serum
or plasma (lithium heparin) using the
ELFA technique (Enzyme Linked
Fluorescent Assay).
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
T3/TRIIODOTHYRONINE
Solid Phase Receptacle
• The interior of the SPR is coated
during production with anti-T3
antibodies (sheep)
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
T3/TRIIODOTHYRONINE
STRIP - WELL
• The well of the strip is contained with
T3 antigen labeled with alkaline
phosphatase (conjugate)
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
T3/TRIIODOTHYRONINE
PRINCIPLE
T3/TRIIODOTHYRONINE
PRINCIPLE
T3/TRIIODOTHYRONINE
PRINCIPLE
T3/TRIIODOTHYRONINE
PRINCIPLE
The mixture is
cycled in and out
of the SPR
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
T3/TRIIODOTHYRONINE
PRINCIPLE The mixture of T3
antigen and T3 Antigen
labeled with Alkaline
Phosphatase will
compete with the
limited binding site of
the anti-T3 antibodies
(sheep) present
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
T3/TRIIODOTHYRONINE
PRINCIPLE
T3/TRIIODOTHYRONINE
PRINCIPLE
Catalyzes the
hydrolysis of this
substrate into a
fluorescent (4-methyl-
umbelliferone) and
measured at 450nm
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
T3/TRIIODOTHYRONINE: PROCEDURE
T3/TRIIODOTHYRONINE
T4/THYROXINE
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
T3/TRIIODOTHYRONINE
• the determination of total thyroxine
(T4) in human serum and plasma
(lithium heparin) using the ELFA
technique (Enzyme Linked Fluorescent
Assay).
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
T4/THYROXINE
Solid Phase Receptacle
• The interior of the SPR is coated
during production with anti-T4
antibodies
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
T4/THYROXINE
STRIP - WELL
• The well of the strip is contained with
T4 antigen labeled with alkaline
phosphatase (conjugate)
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
T4/THYROXINE
PRINCIPLE
T4/THYROXINE
PRINCIPLE
T4/THYROXINE
PRINCIPLE
T4/THYROXINE
PRINCIPLE
The mixture is
cycled in and out
of the SPR
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
T4/THYROXINE
PRINCIPLE The mixture of T4
antigen and T4 Antigen
labeled with Alkaline
Phosphatase will
compete with the
limited binding site of
the anti-T43
antibodies present
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
T4/THYROXINE
PRINCIPLE
T4/THYROXINE
PRINCIPLE
Catalyzes the
hydrolysis of this
substrate into a
fluorescent (4-methyl-
umbelliferone) and
measured at 450nm
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
T4/THYROXINE: PROCEDURE
T4/THYROXINE
TSH/T3/T4
CONSIDERATION, LIMITATION &
STORAGE
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
TSH/T3/T4
LIMITATIONS OF THE METHOD
• Interference may be encountered
with certain sera containing
antibodies directed against reagent
components.
• Must be interpreted as part of a
complete clinical profile
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
TSH/T3/T4
STORAGE CONSIDERATION
• Storage Temperature @ 2 to 8°C
• Do not freeze the SPRs and Strips
• Check for correct sealed and
undamaged SPR pouches
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
TSH/T3/T4
SAMPLE CONSIDERATIONS
Hemolysis
Lipemia
2 to 8°C for 48 hours Bilirubinemia
-25+-6°C for 2 months
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
TSH/T3/T4
CALIBRATION
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C
anti-TSH Serum,
Thyroid
Anti-TSH Immuno Plasma
Stimulating 200uL 40 min 0.05 to 60uIU/mL Proportional
Antibody globulins (Hep.,
Hormone
(mouse) Beads, Gel)
anti-T3 Heparinized
T3 T3 Inversely
antibodi Serum or 100uL 40 min 0.4 to 9nmol/L
Triiodothyronine Antigen Proportional
es Plasma
anti-T4 Heparinized
T4 T4 Inversely
antibodi Serum, 200uL 40 min 6 to 320nmol/L
Thyroxine Antigen Proportional
es Plasma
THYROID PANEL
CLINICAL CHEMISTRY 3 LABORATORY | MLS4C